当前位置:首页 - 行情中心 - 汉森制药(002412) - 财务分析 - 现金流量表

汉森制药

(002412)

  

流通市值:31.26亿  总市值:31.60亿
流通股本:4.98亿   总股本:5.03亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金778,437,939.74546,253,645.98255,364,690.85966,151,105.91
  收到的税费返还-0--
  收到其他与经营活动有关的现金5,594,746.894,491,075.751,372,259.2621,693,877.93
  经营活动现金流入小计784,032,686.63550,744,721.73256,736,950.11987,844,983.84
  购买商品、接受劳务支付的现金105,023,117.9473,024,350.1737,387,993.76123,159,449.01
  支付给职工以及为职工支付的现金167,186,844.57115,545,609.7367,477,182.22192,045,271.31
  支付的各项税费130,616,387.15103,710,305.1342,457,086.08192,732,614.77
  支付其他与经营活动有关的现金219,395,116.04148,362,698.4260,007,606.3349,123,852.76
  经营活动现金流出小计622,221,465.7440,642,963.45207,329,868.36857,061,187.85
  经营活动产生的现金流量净额161,811,220.93110,101,758.2849,407,081.75130,783,795.99
二、投资活动产生的现金流量:
  收回投资收到的现金1,138,000,000806,000,000296,500,0001,002,733,752.42
  取得投资收益收到的现金2,996,369.642,199,250.141,465,601.1616,231,339.93
  处置固定资产、无形资产和其他长期资产收回的现金净额27,075.461,775.66-2,927.44
  处置子公司及其他营业单位收到的现金净额-0--
  收到的其他与投资活动有关的现金247,500247,500-1,477,210.3
  投资活动现金流入小计1,141,270,945.1808,448,525.8297,965,601.161,020,445,230.09
  购建固定资产、无形资产和其他长期资产支付的现金12,504,370.578,688,480.214,846,011.211,635,432.29
  投资支付的现金1,261,300,000875,200,000381,900,0001,041,000,000
  质押贷款净增加额-0--
  取得子公司及其他营业单位支付的现金-0--
  支付其他与投资活动有关的现金-0-10,000,000
  投资活动现金流出小计1,273,804,370.57883,888,480.21386,746,011.21,062,635,432.29
  投资活动产生的现金流量净额-132,533,425.47-75,439,954.41-88,780,410.04-42,190,202.2
三、筹资活动产生的现金流量:
  吸收投资收到的现金-0--
  其中:子公司吸收少数股东投资收到的现金-0--
  取得借款收到的现金50,000,00050,000,000-84,379,176
  收到其他与筹资活动有关的现金00--
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计50,000,00050,000,000-84,379,176
  偿还债务支付的现金78,000,00068,000,000-95,000,000
  分配股利、利润或偿付利息支付的现金1,419,0001,093,458.32360,4752,551,336.23
  其中:子公司支付给少数股东的股利、利润-0--
  支付其他与筹资活动有关的现金00--
  筹资活动现金流出小计79,419,00069,093,458.32360,47597,551,336.23
  筹资活动产生的现金流量净额-29,419,000-19,093,458.32-360,475-13,172,160.23
五、现金及现金等价物净增加额-141,204.5415,568,345.55-39,733,803.2975,421,433.56
  加:期初现金及现金等价物余额126,548,637.4126,548,637.4126,548,637.451,127,203.84
  期末现金及现金等价物余额126,407,432.86142,116,982.9586,814,834.11126,548,637.4
补充资料:
  净利润-68,538,438.13-220,244,409.11
  资产减值准备--3,834.07-126,720.18
  固定资产和投资性房地产折旧-19,075,283.82-39,300,218.07
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-19,075,283.82-39,300,218.07
  无形资产摊销-777,330.52-1,463,462.92
  长期待摊费用摊销-371,525.55-718,684.08
  处置固定资产、无形资产和其他长期资产的损失-448,853.73--
  固定资产报废损失-121.46-165,988.47
  公允价值变动损失--898,900.83--2,073,590.91
  财务费用-899,865.74-2,007,566.8
  投资损失-39,497,582.73--9,972,397.05
  递延所得税--2,787.34--153,531.68
  其中:递延所得税资产减少-127,032.62-72,757.71
    递延所得税负债增加--129,819.96--226,289.39
  存货的减少-15,895,670.75-8,183,802.5
  经营性应收项目的减少--18,504,622.58--110,318,546.04
  经营性应付项目的增加--17,569,196.53--18,549,899.25
  其他--1,092,414.58--
  现金的期末余额-142,116,982.95-126,548,637.4
  减:现金的期初余额-126,548,637.4-51,127,203.84
  现金及现金等价物的净增加额-15,568,345.55-75,421,433.56
公告日期2025-10-282025-08-262025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑